Related Experiment Video
Updated: May 4, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Cardioprotection during diabetes: the role of mitochondrial DNA
Maria Muravyeva1, Ines Baotic, Martin Bienengraeber
1From the Department of Anesthesiology (M.M., I.B., M.B., Z.J.B., F.S., D.C.W., and J.R.K.), Department of Pharmacology and Toxicology (M.B., D.C.W., and J.R.K.), and Department of Physiology (Z.J.B.), Medical College of Wisconsin, Milwaukee, Wisconsin; and The Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin (J.L.).
Background:
Diabetes alters mitochondrial bioenergetics and consequently disrupts cardioprotective signaling. The authors investigated whether mitochondrial DNA (mtDNA) modulates anesthetic preconditioning (APC) and cardiac susceptibility to ischemia-reperfusion injury by using two strains of rats, both sharing nuclear genome of type 2 diabetes mellitus (T2DN) rats and having distinct mitochondrial genomes of Wistar and fawn-hooded hypertensive (FHH) rat strains (T2DN(mtWistar) and T2DN(mtFHH), respectively).
Methods:
Myocardial infarct size was measured in Wistar, T2DN(mtWistar), and T2DN(mtFHH) rats with or without APC (1.4% isoflurane) in the presence or absence of antioxidant N-acetylcysteine. Flavoprotein fluorescence intensity, a marker of mitochondrial redox state, 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity, a marker of reactive oxygen species generation, and mitochondrial permeability transition pore opening were assessed in isolated rat ventricular cardiomyocytes with or without isoflurane (0.5 mmol/l).
Results:
Myocardial infarct size was decreased by APC in Wistar and T2DN(mtWistar) rats (to 42 ± 6%, n = 8; and 44 ± 7%, n = 8; of risk area, respectively) compared with their respective controls (60 ± 3%, n = 6; and 59 ± 9%, n = 7), but not in T2DN(mtFHH) rats (60 ± 2%, n = 8). N-acetylcysteine applied during isoflurane treatment restored APC in T2DN(mtFHH) (39 ± 6%, n = 7; and 38 ± 5%, n = 7; 150 and 75 mg/kg N-acetylcysteine, respectively), but abolished protection in control rats (54 ± 8%, n = 6). Similar to the data on infarct size, APC delayed mitochondrial permeability transition pore opening in T2DN(mtWistar) but not in T2DN(mtFHH) cardiomyocytes. Isoflurane increased flavoprotein and 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity in all rat strains, with the greatest effect in T2DN(mtFHH) cardiomyocytes.
Conclusion:
Differences in the mitochondrial genome modulate isoflurane-induced generation of reactive oxygen species which translates into differential susceptibility to APC and ischemia-reperfusion injury in diabetic rats.
Insights
Mitochondrial DNA differences affect how well anesthetic preconditioning protects diabetic rats against heart injury. This study shows mitochondrial genome variations influence reactive oxygen species generation, impacting protection from ischemia-reperfusion injury.
Area of Science:
- Cardiovascular Science
- Mitochondrial Biology
- Anesthesiology
Background:
- Diabetes mellitus (DM) impairs mitochondrial function and cardioprotective signaling.
- Mitochondrial DNA (mtDNA) plays a role in DM-induced cardiac dysfunction.
- Investigating mtDNA's role in anesthetic preconditioning (APC) and ischemia-reperfusion (I/R) injury is crucial.
Purpose of the Study:
- To determine if mtDNA modulates APC efficacy in diabetic rats.
- To assess the impact of distinct mitochondrial genomes on cardiac susceptibility to I/R injury.
- To elucidate the mechanisms underlying APC in diabetic conditions.
Main Methods:
- Utilized two rat strains with identical nuclear genomes but different mtDNA (T2DN(mtWistar) and T2DN(mtFHH)).
- Measured myocardial infarct size with and without APC (isoflurane) and N-acetylcysteine (NAC).
- Assessed mitochondrial redox state, reactive oxygen species (ROS) generation, and mitochondrial permeability transition pore (MPTP) opening in cardiomyocytes.
Main Results:
- APC reduced infarct size in Wistar and T2DN(mtWistar) rats but not in T2DN(mtFHH) rats.
- NAC restored APC in T2DN(mtFHH) rats and abolished protection in control rats.
- APC delayed MPTP opening in T2DN(mtWistar) but not T2DN(mtFHH) cardiomyocytes; isoflurane increased ROS production, most notably in T2DN(mtFHH) cardiomyocytes.
Conclusions:
- Mitochondrial genome variations significantly influence the susceptibility of diabetic hearts to I/R injury.
- mtDNA modulates isoflurane-induced ROS generation, thereby affecting APC efficacy.
- Targeting mtDNA-related pathways may offer novel therapeutic strategies for cardioprotection in diabetic patients.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
10:31Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
Published on: September 29, 2017
Related Concept Videos
Animal Mitochondrial Genetics
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Cardiomyopathy II: Dilated Cardiomyopathy